These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25176194)

  • 1. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
    Sun S; Jia Q; Zenova AY; Chafeev M; Zhang Z; Lin S; Kwan R; Grimwood ME; Chowdhury S; Young C; Cohen CJ; Oballa RM
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4397-4401. PubMed ID: 25176194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of morpholine-based aryl sulfonamides as Na
    Wu YJ; Guernon J; McClure A; Venables B; Rajamani R; Robbins KJ; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
    Bioorg Med Chem Lett; 2018 Mar; 28(5):958-962. PubMed ID: 29439904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na
    Swain NA; Batchelor D; Beaudoin S; Bechle BM; Bradley PA; Brown AD; Brown B; Butcher KJ; Butt RP; Chapman ML; Denton S; Ellis D; Galan SRG; Gaulier SM; Greener BS; de Groot MJ; Glossop MS; Gurrell IK; Hannam J; Johnson MS; Lin Z; Markworth CJ; Marron BE; Millan DS; Nakagawa S; Pike A; Printzenhoff D; Rawson DJ; Ransley SJ; Reister SM; Sasaki K; Storer RI; Stupple PA; West CW
    J Med Chem; 2017 Aug; 60(16):7029-7042. PubMed ID: 28682065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia.
    Wu W; Li Z; Yang G; Teng M; Qin J; Hu Z; Hou L; Shen L; Dong H; Zhang Y; Li J; Chen S; Tian J; Zhang J; Ye L
    Bioorg Med Chem Lett; 2017 May; 27(10):2210-2215. PubMed ID: 28385504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Novel Class of State-Dependent Na
    Tanaka K; Kobayashi H; Suzuki S; Shibuya S; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Shinozuka T
    Chem Pharm Bull (Tokyo); 2020; 68(7):653-663. PubMed ID: 32612000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Potent, Selective, and State-Dependent Na
    Ramdas V; Talwar R; Kanoje V; Loriya RM; Banerjee M; Patil P; Joshi AA; Datrange L; Das AK; Walke DS; Kalhapure V; Khan T; Gote G; Dhayagude U; Deshpande S; Shaikh J; Chaure G; Pal RR; Parkale S; Suravase S; Bhoskar S; Gupta RV; Kalia A; Yeshodharan R; Azhar M; Daler J; Mali V; Sharma G; Kishore A; Vyawahare R; Agarwal G; Pareek H; Budhe S; Nayak A; Warude D; Gupta PK; Joshi P; Joshi S; Darekar S; Pandey D; Wagh A; Nigade PB; Mehta M; Patil V; Modi D; Pawar S; Verma M; Singh M; Das S; Gundu J; Nemmani K; Bock MG; Sharma S; Bakhle D; Kamboj RK; Palle VP
    J Med Chem; 2020 Jun; 63(11):6107-6133. PubMed ID: 32368909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonamides as Selective Na
    Graceffa RF; Boezio AA; Able J; Altmann S; Berry LM; Boezio C; Butler JR; Chu-Moyer M; Cooke M; DiMauro EF; Dineen TA; Feric Bojic E; Foti RS; Fremeau RT; Guzman-Perez A; Gao H; Gunaydin H; Huang H; Huang L; Ilch C; Jarosh M; Kornecook T; Kreiman CR; La DS; Ligutti J; Milgram BC; Lin MJ; Marx IE; Nguyen HN; Peterson EA; Rescourio G; Roberts J; Schenkel L; Shimanovich R; Sparling BA; Stellwagen J; Taborn K; Vaida KR; Wang J; Yeoman J; Yu V; Zhu D; Moyer BD; Weiss MM
    J Med Chem; 2017 Jul; 60(14):5990-6017. PubMed ID: 28324649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonamides as Selective Na
    Weiss MM; Dineen TA; Marx IE; Altmann S; Boezio A; Bregman H; Chu-Moyer M; DiMauro EF; Feric Bojic E; Foti RS; Gao H; Graceffa R; Gunaydin H; Guzman-Perez A; Huang H; Huang L; Jarosh M; Kornecook T; Kreiman CR; Ligutti J; La DS; Lin MJ; Liu D; Moyer BD; Nguyen HN; Peterson EA; Rose PE; Taborn K; Youngblood BD; Yu V; Fremeau RT
    J Med Chem; 2017 Jul; 60(14):5969-5989. PubMed ID: 28287723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.
    Suzuki S; Kuroda T; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Sugita R; Koishi R; Asano D; Tamaki K; Shinozuka T; Kobayashi H
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5419-23. PubMed ID: 26358159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNa
    Focken T; Chowdhury S; Zenova A; Grimwood ME; Chabot C; Sheng T; Hemeon I; Decker SM; Wilson M; Bichler P; Jia Q; Sun S; Young C; Lin S; Goodchild SJ; Shuart NG; Chang E; Xie Z; Li B; Khakh K; Bankar G; Waldbrook M; Kwan R; Nelkenbrecher K; Karimi Tari P; Chahal N; Sojo L; Robinette CL; White AD; Chen CA; Zhang Y; Pang J; Chang JH; Hackos DH; Johnson JP; Cohen CJ; Ortwine DF; Sutherlin DP; Dehnhardt CM; Safina BS
    J Med Chem; 2018 Jun; 61(11):4810-4831. PubMed ID: 29737846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
    Sun S; Cohen CJ; Dehnhardt CM
    Pharm Pat Anal; 2014 Sep; 3(5):509-21. PubMed ID: 25374320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery and optimization of benzimidazoles as selective Na
    Brown AD; Bagal SK; Blackwell P; Blakemore DC; Brown B; Bungay PJ; Corless M; Crawforth J; Fengas D; Fenwick DR; Gray V; Kemp M; Klute W; Malet Sanz L; Miller D; Murata Y; Payne CE; Skerratt S; Stevens EB; Warmus JS
    Bioorg Med Chem; 2019 Jan; 27(1):230-239. PubMed ID: 30538065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Na
    McKerrall SJ; Sutherlin DP
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of benzoxazine sulfonamide inhibitors of Na
    La DS; Peterson EA; Bode C; Boezio AA; Bregman H; Chu-Moyer MY; Coats J; DiMauro EF; Dineen TA; Du B; Gao H; Graceffa R; Gunaydin H; Guzman-Perez A; Fremeau R; Huang X; Ilch C; Kornecook TJ; Kreiman C; Ligutti J; Jasmine Lin MH; McDermott JS; Marx I; Matson DJ; McDonough SI; Moyer BD; Nho Nguyen H; Taborn K; Yu V; Weiss MM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3477-3485. PubMed ID: 28629594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na
    Roecker AJ; Egbertson M; Jones KLG; Gomez R; Kraus RL; Li Y; Koser AJ; Urban MO; Klein R; Clements M; Panigel J; Daley C; Wang J; Finger EN; Majercak J; Santarelli V; Gregan I; Cato M; Filzen T; Jovanovska A; Wang YH; Wang D; Joyce LA; Sherer EC; Peng X; Wang X; Sun H; Coleman PJ; Houghton AK; Layton ME
    Bioorg Med Chem Lett; 2017 May; 27(10):2087-2093. PubMed ID: 28389149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na
    Sun S; Jia Q; Zenova AY; Wilson MS; Chowdhury S; Focken T; Li J; Decker S; Grimwood ME; Andrez JC; Hemeon I; Sheng T; Chen CA; White A; Hackos DH; Deng L; Bankar G; Khakh K; Chang E; Kwan R; Lin S; Nelkenbrecher K; Sellers BD; DiPasquale AG; Chang J; Pang J; Sojo L; Lindgren A; Waldbrook M; Xie Z; Young C; Johnson JP; Robinette CL; Cohen CJ; Safina BS; Sutherlin DP; Ortwine DF; Dehnhardt CM
    J Med Chem; 2019 Jan; 62(2):908-927. PubMed ID: 30499663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of N-(((1S,3R,5S)-adamantan-1-yl)methyl)-3-((4-chlorophenyl)sulfonyl)benzenesulfonamide as novel Nav1.8 inhibitor with analgesic profile.
    Song C; Qiu J; Luo M; Fu Y; Hu S; Liu W; Zhang D; Chen M; Cao Z; Yang X; Ke B
    Bioorg Med Chem Lett; 2024 Sep; 110():129862. PubMed ID: 38944398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.
    Murray JK; Biswas K; Holder JR; Zou A; Ligutti J; Liu D; Poppe L; Andrews KL; Lin FF; Meng SY; Moyer BD; McDonough SI; Miranda LP
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4866-4871. PubMed ID: 26112439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.
    DiMauro EF; Altmann S; Berry LM; Bregman H; Chakka N; Chu-Moyer M; Bojic EF; Foti RS; Fremeau R; Gao H; Gunaydin H; Guzman-Perez A; Hall BE; Huang H; Jarosh M; Kornecook T; Lee J; Ligutti J; Liu D; Moyer BD; Ortuno D; Rose PE; Schenkel LB; Taborn K; Wang J; Wang Y; Yu V; Weiss MM
    J Med Chem; 2016 Sep; 59(17):7818-39. PubMed ID: 27441383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations.
    Wang M; Wang Y; Kong D; Jiang H; Wang J; Cheng M
    Comput Biol Chem; 2018 Dec; 77():214-225. PubMed ID: 30359866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.